These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 134465)

  • 1. Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasma.
    Hender U; Collen D
    Thromb Res; 1976 Jun; 8(6):875-9. PubMed ID: 134465
    [No Abstract]   [Full Text] [Related]  

  • 2. Inter-alpha-antiplasmin: its distinction from antiactivator.
    Gallimore MJ
    Thromb Res; 1978 Apr; 12(4):687-92. PubMed ID: 149395
    [No Abstract]   [Full Text] [Related]  

  • 3. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
    Booth NA; Anderson JA; Bennett B
    Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Distinction of plasma inhibitor of activator-induced clot lysis from antiplasmins.
    Aoki N; Matsuda M; Moroi M; Yoshida N
    Thromb Diath Haemorrh; 1975 Sep; 34(1):350. PubMed ID: 127401
    [No Abstract]   [Full Text] [Related]  

  • 5. [Method of determination of total content of plasminogen, plasminogen proactivator, inhibitors of plasminogen activation and antiplasmins in the blood plasma].
    Aslanian NL; Shukhian VM; Barsegian LKh; Ambartsumian KL
    Lab Delo; 1977; (9):530-2. PubMed ID: 72873
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural inhibitors of fibrinolysis.
    Collen D
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.
    Lijnen HR; Collen D
    Semin Thromb Hemost; 1982 Jan; 8(1):2-10. PubMed ID: 6460318
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies on human activators of plasminogen.
    Mackie M; Booth NA; Bennett B
    Br J Haematol; 1981 Jan; 47(1):77-90. PubMed ID: 6449216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibrinolytic system and its relation to inflammatory diseases.
    Clemmensen I; Andersen RB
    Semin Arthritis Rheum; 1982 May; 11(4):390-8. PubMed ID: 6179164
    [No Abstract]   [Full Text] [Related]  

  • 10. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
    Crutchley DJ; Conanan LB; Maynard JR
    Ann N Y Acad Sci; 1981; 370():609-16. PubMed ID: 6455956
    [No Abstract]   [Full Text] [Related]  

  • 11. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of plasminogen activator associated with chronic granulomatous inflammation.
    Goldstein SM; Izaki S; Epstein WL
    Thromb Res; 1979; 16(5-6):727-35. PubMed ID: 160627
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of a plasmin A-chain/t-PA B-chain hybrid enzyme with plasma inhibitors in vivo and in vitro.
    Wilson S; Chamberlain P; Dodd I; Esmail A; Robinson JH
    Thromb Haemost; 1990 Jun; 63(3):459-63. PubMed ID: 1698316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
    Walker B; Elmore DT
    Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of a partially purified preparation of a circulating plasminogen activator.
    Ogston D; Bennett B; Mackie M
    Thromb Res; 1976 Mar; 8(3):275-84. PubMed ID: 131386
    [No Abstract]   [Full Text] [Related]  

  • 16. [The identification of inhibitors of acantholysis of pemphigus vulgaris].
    Naito K
    Nihon Hifuka Gakkai Zasshi; 1987 Oct; 97(11):1231-8. PubMed ID: 2965270
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme.
    Danø K; Nielsen LS; Møller V; Engelhart M
    Biochim Biophys Acta; 1980 Jun; 630(1):146-51. PubMed ID: 6248125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of the enzyme activity of the fibrinolytic system using fibrinogen conjugated with peroxidase].
    Liaginskiĭ AV; AfanasenkoGA ; Gudkova EV
    Lab Delo; 1991; (11):27-31. PubMed ID: 1722843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.